FOXM1 and cancer: Although inhibition of Aurora‐A kinase was a promising regimen for TNBC cancer therapy, the results presented here suggested that the use of an antibiotic drug thiostrepton, which is capable of directly down‐regulating Aurora‐A and FOXM1 level, could synergize with paclitaxel to reverse paclitaxel chemoresistance in TNBC.